Abstract
Objective: Residual tumor is the most important prognostic factor in advanced ovarian cancer patients. A recent analysis from a large GOG trial identified the diaphragm as the most common localization for residual tumor after surgery in advanced ovarian cancer. This stresses the need for more knowledge and training in diaphragmatic surgery in patients with advanced ovarian cancer.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have